CLDI$0.6882.43%0.0163
After Hours: 0.71+0.02 +3.20%
Calidi Biotherapeutics Inc (CLDI)
Date: 2026-10-30 16:00O: 0.6670H: 0.6880L: 0.6446C: 0.6880Vol: 48.39k
Calidi Biotherapeutics Inc stock is traded at $0.688, with a volume of 48,394. It is up +2.43% in the last 24 hours and down -35.70% over the past month. Calidi Biotherapeutics Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. It engages in advancing a potent allogeneic stem cell capable of carrying an anti-tumor payload for use in multiple oncology indications, including high-grade gliomas and solid tumors. The company's cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Its pipeline of products candidates in the clinic includes NeuroNova that are allogeneic neural stem cells loaded with an oncolytic adenovirus for the treatment of high-grade gliomas; and SuperNova, which are allogeneic adipose-derived mesenchymal stem cells loaded with tumor-selective CAL1 oncolytic vaccinia virus for the treatment of advanced metastatic solid tumors. The company was founded in 2014 and is headquartered in San Diego, California.
Previous Close:
$0.6717
Open:
$0.667
24h Volume:
48,394
Relative Volume:
0.85
Market Cap:
$1.78M
Revenue:
-
Net Income/Loss:
-$25.09M
P/E Ratio:
-
EPS:
-$5.18
Net Cash Flow:
-$18.40M
1W Performance:
+6.67%
1M Performance:
-35.70%
6M Performance:
-81.86%
1Y Performance:
-97.28%
1-Day Range:
$0.6446$0.688
1-Week Range:
$0.6225$0.7189
52-Week Range:
$0.62$27.04
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Name
Calidi Biotherapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
(858) 794-9600Address
4475 Executive Drive, Suite 200, San Diego, USACompare CLDI vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLDI Calidi Biotherapeutics Inc | $0.688 | $1.78M | $0 | -$25.09M | -$18.40M | -$5.18 |
 VRTX Vertex Pharmaceuticals Inc | $558.88 | $141.65B | $12.34B | $4.34B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $927.89 | $95.53B | $14.92B | $4.42B | $3.79B | $41.04 |
 MRNA Moderna Inc | $221.72 | $88.52B | $2.23B | -$3.19B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $892.87 | $56.15B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $370.33 | $41.89B | $5.76B | $514.49M | $1.10B | $4.48 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
Calidi Biotherapeutics Inc Stock (CLDI) Financials Data
Revenue
Chart is being upgraded
This chart will be back soon.
